Epizyme Total Assets 2012-2022 | EPZM
Epizyme total assets from 2012 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Epizyme Annual Total Assets
(Millions of US $) |
| 2021 |
$289 |
| 2020 |
$474 |
| 2019 |
$425 |
| 2018 |
$276 |
| 2017 |
$289 |
| 2016 |
$252 |
| 2015 |
$218 |
| 2014 |
$199 |
| 2013 |
$163 |
| 2012 |
$104 |
| 2011 |
$37 |
Epizyme Quarterly Total Assets
(Millions of US $) |
| 2022-03-31 |
$312 |
| 2021-12-31 |
$289 |
| 2021-09-30 |
$332 |
| 2021-06-30 |
$353 |
| 2021-03-31 |
$407 |
| 2020-12-31 |
$474 |
| 2020-09-30 |
$382 |
| 2020-06-30 |
$427 |
| 2020-03-31 |
$452 |
| 2019-12-31 |
$425 |
| 2019-09-30 |
$334 |
| 2019-06-30 |
$371 |
| 2019-03-31 |
$413 |
| 2018-12-31 |
$276 |
| 2018-09-30 |
$203 |
| 2018-06-30 |
$239 |
| 2018-03-31 |
$260 |
| 2017-12-31 |
$289 |
| 2017-09-30 |
$321 |
| 2017-06-30 |
$205 |
| 2017-03-31 |
$224 |
| 2016-12-31 |
$252 |
| 2016-09-30 |
$279 |
| 2016-06-30 |
$301 |
| 2016-03-31 |
$323 |
| 2015-12-31 |
$218 |
| 2015-09-30 |
$238 |
| 2015-06-30 |
$245 |
| 2015-03-31 |
$253 |
| 2014-12-31 |
$199 |
| 2014-09-30 |
$221 |
| 2014-06-30 |
$238 |
| 2014-03-31 |
$251 |
| 2013-12-31 |
$163 |
| 2013-09-30 |
$147 |
| 2013-06-30 |
$162 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$0 |
| 2012-09-30 |
$0 |
| 2012-06-30 |
$0 |
| 2011-12-31 |
$37 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.086B |
$0.037B |
|
Epizyme, Inc. is a biopharmaceutical company. It engages in the discovery, development, planning, and commercialization of therapeutics for cancers. Epizyme, Inc. is headquartered in Cambridge, Massachusetts.
|
